1. "Michael Berger"
Formats
  1. Meeting Abstract (424)
  2. Journal Article (323)
  3. Research Letter (9)
  4. Editorial (3)
  5. Guidelines (2)
  6. Review (2)
  7. Book Section (1)
  8. Conference Paper (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (765)
  2. Department of Pathology and Laboratory Medicine (765)
  3. GSK Faculty (765)
  4. Human Oncology and Pathogenesis Program (765)
  5. Department of Medicine (607)
  6. Solid Tumor Oncology Division (578)

More Groups

People
  1. Michael Berger (765)
  2. David Solit (315)
  3. Marc Ladanyi (219)
  4. Ahmet Zehir (190)
  5. Maria Arcila (162)
  6. Nikolaus Schultz (157)

More People

Years
  1. 2025 (15)
  2. 2024 (47)
  3. 2023 (55)
  4. 2022 (56)
  5. 2021 (40)
  6. 2020 (47)

More Years

Publications
  1. Journal of Clinical Oncology (154)
  2. Cancer Research (67)
  3. Modern Pathology (65)
  4. Clinical Cancer Research (52)
  5. Laboratory Investigation (52)
  6. Journal of Molecular Diagnostics (38)

More Publications

Publishers
  1. American Society of Clinical Oncology (176)
  2. American Association for Cancer Research (145)
  3. Nature Publishing Group (109)
  4. Nature Research (68)
  5. Elsevier Science, Inc. (46)
  6. Oxford University Press (39)

More Publishers

Results (765)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of metastasis and survival in patients with PI3K-aberrant and FGFR1 amplified stage IV squamous cell lung cancers (SQCLCs)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Rekhtman, N.; Sima, C. S.; Won, H.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Targeted cancer genome sequencing in thymic epithelial tumors
    Meeting Abstract

    Moreira, A.; McMillan, R.; Won, H.; Huang, J.; Riely, G.; Ladanyi, M.; Berger, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Delineating genomic heterogeneity in paired primary and metastatic colorectal cancer by massively parallel sequencing
    Meeting Abstract

    Brannon, A. R.; Vakiani, E.; Scott, S. N.; Sylvester, B.; Kania, K.; Viale, A.; Kemeny, N.; Weiser, M.; Solit, D. B.; Berger, M. F.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Dissecting the clonal hierarchy of cancer-driving genomic lesions
    Meeting Abstract

    Prandi, D.; Baca, S. C.; Lawrence, M. S.; Mosquera, J. M.; Romanel, A.; Drier, Y.; Park, K.; Kitabayashi, N.; MacDonald, T. Y.; Van Allen, E.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Punctuated evolution of prostate cancer genomes
    Meeting Abstract

    Baca, S. C.; Prandi, D.; Lawrence, M. S.; Mosquera, J. M.; Romanei, A.; Drier, Y.; Park, K.; Kitabayashi, N.; MacDonald, T. Y.; Van Allen, E.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Massively parallel sequencing analysis of clinical samples: Challenges and opportunities
    Meeting Abstract

    Berger, M.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • A paired-sample snalysis pipeline for removing artifacts in point mutation calls made from the Illumina TruSeq Amplicon Cancer Panel (TSACP) assay
    Meeting Abstract

    Zehir, A.; Mitchell, T.; Cheng, W. J.; Oultache, A.; Nafa, K.; Arcila, M. E.; Berger, M. F.; Cheng, D. T.; Hedvat, C. V.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save
  • Clinical validation of an amplicon-based next-generation sequencing assay for formalin-fixed, paraffin-embedded solid tumors
    Meeting Abstract

    Oultache, A.; Nafa, K.; Mitchell, T. N.; Sadowska, J.; Zehir, A.; Cheng, D.; Arcila, M. E.; Berger, M. F.; Hameed, M. R.; Hedvat, C. V.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save